ContentServer.asp-9.pdf - A Progressive Digital Media business COMPANY PROFILE Teva Pharmaceutical Industries Limited REFERENCE CODE

ContentServer.asp-9.pdf - A Progressive Digital Media...

This preview shows page 1 - 5 out of 9 pages.

COMPANY PROFILE Teva Pharmaceutical Industries Limited REFERENCE CODE: 70912FAE-F66F-4F80-8DB6-426797025AC6 PUBLICATION DATE : 18 Aug 2017 COPYRIGHT MARKETLINE. THIS CONTENT IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED OR DISTRIBUTED A Progressive Digital Media business
Image of page 1
Teva Pharmaceutical Industries Limited TABLE OF CONTENTS Teva Pharmaceutical Industries Limited © MarketLine Page 2 TABLE OF CONTENTS Company Overview ........................................................................................................ 3 Key Facts ......................................................................................................................... 3 SWOT Analysis ............................................................................................................... 4
Image of page 2
Teva Pharmaceutical Industries Limited Company Overview Teva Pharmaceutical Industries Limited © MarketLine Page 3 Company Overview COMPANY OVERVIEW Teva Pharmaceutical Industries Limited (Teva or 'the company') is a generic pharmaceutical company. Teva is engaged in the development, production and marketing of generic, proprietary branded pharmaceuticals and active pharmaceutical ingredients. The company conducts its operations primarily in the Americas, Europe and Asia. It is headquartered in Petach Tikva, Israel. The company reported revenues of (US Dollars) US$21,903 million for the fiscal year ended December 2016 (FY2016), an increase of 11.5% over FY2015. In FY2016, the company’s operating margin was 5.8%, compared to an operating margin of 13.1% in FY2015. In FY2016, the company recorded a net margin of 1.5%, compared to a net margin of 8.1% in FY2015. Key Facts KEY FACTS Head Office Teva Pharmaceutical Industries Limited 5 Basel St., P.O. Box 3190 PETAH TIKVA Petah Tikva PETAH TIKVA Petah Tikva ISR Phone 972 3 914 8171 Fax 972 3 914 8678 Web Address Revenue / turnover (USD Mn) 21,903.0 Financial Year End December Employees 56,960 The Tel-Aviv Stock Exchange Ticker TEVA
Image of page 3
Teva Pharmaceutical Industries Limited SWOT Analysis Teva Pharmaceutical Industries Limited © MarketLine Page 4 SWOT Analysis SWOT ANALYSIS Teva Pharmaceutical Industries (Teva or 'the company') is the leading generic pharmaceutical companies in the world. It is engaged in the development, production and marketing of generic, proprietary branded pharmaceuticals and active APIs. The company's size and scale advantages have made it the leader in the global generics market. However, continuing consolidation of the company's customer base could affect its profit margins. Strength Size and scale advantages providing leadership position in global generics market Strong R&D capabilities keeping product pipeline robust Aggressive acquisition strategy helps Teva build size and scale Weakness Significant reliance on Copaxone sales Opportunity Acquisition of Auspex Pharmaceuticals likely to help Teva in strengthening its CNS specialty business Positive outlook for global generics market Threat Increasing government scrutiny in the US and Europe may expose Teva to significant damages Continuing consolidation of customer base Strength Size and scale advantages providing leadership position in global generics market Teva is the leader in the global generic medicines industry, with a leading position in the US and in Europe. The company is one of the world's leading manufacturers of APIs, with operations across the globe, and it produces APIs not only for its own use but also for many other pharmaceutical companies.
Image of page 4
Image of page 5

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture